Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization

Macrophages play a central role in tissue remodeling, repair, and resolution of inflammation. Macrophage polarization to Ml or M2 activation status may determine the progression or resolution of the inflammatory response. We have previously reported that cardiotrophin‐1 (CT‐1) displays both cytoprotective and metabolic activities. The role of CT‐1 in inflammation remains poorly understood. Here, we employed recombinant CT‐1 (rCT‐1) and used CT‐1–null mice and myeloid‐specif ic CT‐1 transgenic mice to investigate whether CT‐1 might play a role in the modulation of the inflammatory response. We observed that CT‐1 deficiency was associated with enhanced release of inflammatory mediators and with stronger activation of NF‐κB in response to LPS, whereas the inflammatory response was attenuated in CT‐1 transgenic mice or by administering rCT‐1 to wild‐type animals prior to LPS challenge. We found that CT‐1 promoted IL‐6 expression only by nonhematopoietic cells, whereas LPS up‐regulated IL‐6 expression in both hematopoietic and nonhematopoietic cells. Notably, rCT‐1 inhibited LPS‐mediated soluble IL‐6R induction. Using IL‐6−/− mice, we showed that rCT‐1 inhibited LPS‐induced TNF‐α and IFN‐γ response in an IL‐6–independent manner. Importantly, we demonstrated that CT‐1 primes macrophages for IL‐4–dependent M2 polarization by inducing IL‐4 receptor expression. Mechanistic analyses showed that the signal transducer and activator of transcription 3–suppressor of cytokine signaling 3 axis mediates this effect. Our findings support the notion that CT‐1 is a critical regulator of inflammation and suggest that rCT‐1 could be a molecule with potential therapeutic application in inflammatory conditions.—Carneros, D., Santamaría, E. M., Larequi, E., Vélez‐Ortiz, J. M., Reboredo, M., Mancheño, U., Perugorria, M. J., Navas, P., Romero‐Gómez, M., Prieto, J., Hervás‐Stubbs, S., Bustos, M. Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization. FASEB J. 33, 7578–7587 (2019). www.fasebj.org

[1]  J. T. Afshari,et al.  Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.

[2]  L. Rashed,et al.  A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway , 2018, Inflammation.

[3]  E. McNeill,et al.  Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes , 2017, Antioxidants & redox signaling.

[4]  S. Rose-John The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation , 2017, Clinical pharmacology and therapeutics.

[5]  T. McLaughlin,et al.  Role of innate and adaptive immunity in obesity-associated metabolic disease , 2017, The Journal of clinical investigation.

[6]  G. Carpino,et al.  The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications , 2017, Mediators of inflammation.

[7]  M. Febbraio,et al.  The role of gp130 receptor cytokines in the regulation of metabolic homeostasis , 2016, Journal of Experimental Biology.

[8]  S. McCormick,et al.  Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins , 2015, Front. Immunol..

[9]  H. Hermanns Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. , 2015, Cytokine & growth factor reviews.

[10]  F. Schaper,et al.  Interleukin-6: Biology, signaling and strategies of blockade. , 2015, Cytokine & growth factor reviews.

[11]  M. Moreno-Aliaga,et al.  Cardiotrophin-1: A multifaceted cytokine. , 2015, Cytokine & growth factor reviews.

[12]  Yoshiyuki Hizukuri,et al.  IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. , 2015, International immunology.

[13]  J. Mauer,et al.  Versatile functions for IL-6 in metabolism and cancer. , 2015, Trends in immunology.

[14]  Hongwei Liang,et al.  Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance , 2014, Front. Immunol..

[15]  M. Moreno-Aliaga,et al.  Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. , 2014, Journal of hepatology.

[16]  M. Febbraio,et al.  From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation , 2014, Immunology and cell biology.

[17]  L. Partridge,et al.  Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia , 2016 .

[18]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[19]  J. Pascual,et al.  Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and Inflammation , 2013, Transplantation.

[20]  P. Ward,et al.  Myeloid depletion of SOCS3 enhances LPS‐induced acute lung injury through CCAAT/enhancer binding protein δ pathway , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  J. Prieto,et al.  Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. , 2013, The Journal of surgical research.

[22]  Caroline L. Wilson,et al.  Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll‐like receptor–induced TIMP‐1 gene transcription in hepatic stellate cells in mice , 2013, Hepatology.

[23]  E. Benveniste,et al.  SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation , 2012, The Journal of Immunology.

[24]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[25]  M. Moreno-Aliaga,et al.  Cardiotrophin-1 is a key regulator of glucose and lipid metabolism. , 2011, Cell metabolism.

[26]  C. Libert,et al.  Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. , 2010, Cell metabolism.

[27]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[28]  I. Verma,et al.  Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.

[29]  W. Alexander,et al.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. , 2006, The Journal of clinical investigation.

[30]  K. Nakao,et al.  SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharide-induced left ventricular dysfunction in vivo. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[31]  J. Prieto,et al.  Interplay among cardiotrophin‐1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration , 2005, Hepatology.

[32]  B. Ryffel,et al.  Endogenous leukemia inhibitory factor attenuates endotoxin response , 2005, Laboratory Investigation.

[33]  J. Bae,et al.  CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses1 , 2004, The Journal of Immunology.

[34]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[35]  R. Oppenheim,et al.  Cardiotrophin-1, a Muscle-Derived Cytokine, Is Required for the Survival of Subpopulations of Developing Motoneurons , 2001, The Journal of Neuroscience.

[36]  R. McIntyre,et al.  Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. , 1999, The Journal of surgical research.

[37]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[38]  S. Rose-John,et al.  Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells. , 1997, Journal of immunology.

[39]  P. Ghezzi,et al.  Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. , 1996, The American journal of pathology.

[40]  P. Waring,et al.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Chien,et al.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Fantuzzi,et al.  Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.

[43]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[44]  J. Gauldie,et al.  Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[45]  A. Gaggar,et al.  CALL FOR PAPERS Translational Research in Acute Lung Injury and Pulmonary Fibrosis Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury , 2022 .